Stat News has a report from last month on opposition to the Medicare Part B drug payment reform scheme that highlights the challenge of any reform effort that attempts to line incentives up to more cost effective but clinically similar care. Under the Part B program, doctors, and hospitals buy a medicine, and the government […]
About David Anderson
I'm a research associate at Duke University Margolis Center. I used to be Richard Mayhew, a mid-level bureaucrat at UPMC Health Plan. I started writing here and have not found a reason to stop.
Entries by David Anderson
The first game 7 of the Eastern Conference NHL play-offs is starting in a couple of minutes. It has been a great series but someone will be leaving sad tonight. Let’s go some team…. Open Thread
Thanks to Liz Szabo for willing to chase down a number that we needed in yesterday’s Zika post: @bjdickmayhew The CDC’s Tom Frieden says lifetime costs for microcephaly could be $10 million. — Liz Szabo (@LizSzabo) May 26, 2016 From the CDC on 3/10/2016: we know the cost of caring for one infant with […]
Exchange strategy is dynamic and I think the new round of pricing plus additional insurance company learning by doing will see some significant changes this during this Fall’s open enrollment period. @YFeyman we should expect either a big risk Adjustment play for hi cost plans by 2018 or market exits due to low + expensive […]
I want to focus on the probable consequences of a potential Zika outbreak on Medicaid as a continuation of the discussion that Anne started last night. Zika could be a significant push to rejigger parts of the Legacy medicaid system away from state based funding to a national reinsurance model because of who has high […]